Prevalence and Predictors of Substance Use Disorder Due to Gabapentinoids in Patients With Chronic Non‐Cancer Pain: A Cross‐Sectional Study

Neele Kufeld, Klaus Weckbecker, Eva Münster, Norbert Scherbaum, Michael Specka, Johannes Just · 2026

Read Prevalence and Predictors of Substance Use Disorder Due to Gabapentinoids in Patients With Chronic Non‐Cancer Pain: A Cross‐Sectional Study by Neele Kufeld, Klaus Weckbecker, Eva Münster, Norbert Scherbaum, Michael Specka, Johannes Just (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13412543.txt.

Description

Neele Kufeld and co-authors measure in 2026 how often patients with chronic non-cancer pain develop a substance use disorder tied to gabapentinoid medicines. These drugs are prescribed more widely each year, often off-label, and their misuse risk in ordinary pain patients was poorly quantified. An anonymous questionnaire went to patients treated with gabapentinoids at eleven general practices in two German regions, with 93 responses analysed.

About 27 percent met criteria for at least a mild disorder, and 5.4 percent scored in the severe range on the diagnostic items used. Male sex stood out as the clear predictor in their regression model, roughly quadrupling the odds. The authors advise care when prescribing these drugs for chronic pain and flag the sex difference for study.

Catalog record

CREATORNeele Kufeld, Klaus Weckbecker, Eva Münster, Norbert Scherbaum, Michael Specka, Johannes Just
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE24 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13412543

Browse the full library · About the Tower of Babel